2016-09-21
News
A series of trials have been conducted at the Animal Health Trust, Newmarket, England. The trials were aimed to measure the safety, immunogenicity, efficacy and DIVA (differentiates infected from vaccinated animals) ... Read more
2015-10-28
News
Intervacc is pleased to announce that an agreement has now been signed with PX´Therapeutics, Grenoble, France, for process optimization of Strangvac. PX´Therapeutics, a subsidiary of Aguettant pharmaceutical group, has the ... Read more
2015-08-10
News
The recognized journal Animal Pharm once again highlights Strangvac® in an article about the research now approaching a solution regarding effective vaccine protection against strangles.
The article ... Read more
2014-03-24
Legal Press releases
Stockholm, March 24, 2014
Press release
Intervacc AB (publ) acquires Nordvacc Läkemedel AB and creates a leading player within the veterinary pharmaceutical market in Scandinavia and the Baltic ... Read more